相关实验视频
Updated: Mar 2, 2026

03:52
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
1.4K
与老年人肥胖相关的风险因素:元分析和系统审查
Bingyan Zhao1, Hongyan Li1, Leilei Bao1
1Department of Nursing, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, Zhejiang, China.
Clinical nutrition ESPEN
|February 28, 2026
概括
识别老年人肥胖症的危险因素至关重要. 这一元分析突出了导致这种情况的人口,行为,疾病相关,血脂和营养因素.
科学领域:
- 老年学是指老年学的学科.
- 公共卫生 公共卫生
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 肥胖症在老年人中是一个重要的健康问题,与不良结果有关.
- 了解其风险因素对于有效的干预策略至关重要.
研究的目的:
- 系统地审查和综合与老年人群中sarcopenic肥胖相关的危险因素.
- 分析各个子组风险因素的差异.
主要方法:
- 通过使用来自多个数据库 (PubMed,Embase,Web of Science,Cochrane图书馆,CINAHL) 的数据进行了全面的元分析.
- 纳入标准侧重于在2025年4月20日之前以英语出版的研究.
- 统计分析包括随机效应元分析,子组分析,元回归和使用Stata 17.0.0的Egger测试.
主要成果:
- 该分析包括37项研究,共计90,786名参与者.
- 确定的风险因素包括人口 (年龄,教育,婚姻状况),行为 (运动,不活动,久坐时间),与疾病相关的 (糖尿病,高血压,虚弱),血脂特征 (高脂血症,甘油三,高血糖水平) 和营养因素 (25(OH) D).
结论:
- 这项研究提供了关于老年人形肥胖症关键风险因素的有力证据.
- 这些发现可以为预防和治疗型肥胖症的有针对性的策略提供信息.
相关概念视频
Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Coronary Artery Disease I: Introduction
1.3K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.3K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
324
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
324
Bone Disorders
5.7K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.7K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
273
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
273
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
291
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
291

